CR20210357A - Inhibidores de il-17a de imidazo[1,2-b]piridazina - Google Patents
Inhibidores de il-17a de imidazo[1,2-b]piridazinaInfo
- Publication number
- CR20210357A CR20210357A CR20210357A CR20210357A CR20210357A CR 20210357 A CR20210357 A CR 20210357A CR 20210357 A CR20210357 A CR 20210357A CR 20210357 A CR20210357 A CR 20210357A CR 20210357 A CR20210357 A CR 20210357A
- Authority
- CR
- Costa Rica
- Prior art keywords
- inhibitors
- imidazo
- pyridazine
- formula
- imidazopyridazinyl
- Prior art date
Links
- 102000013691 Interleukin-17 Human genes 0.000 title abstract 2
- 108050003558 Interleukin-17 Proteins 0.000 title abstract 2
- 239000003112 inhibitor Substances 0.000 title abstract 2
- VTVRXITWWZGKHV-UHFFFAOYSA-N imidazo[1,2-b]pyridazine Chemical compound N1=CC=CC2=NC=CN21 VTVRXITWWZGKHV-UHFFFAOYSA-N 0.000 title 1
- KGHLHKZDSODELI-UHFFFAOYSA-N 3-cyclohexyl-4,4-difluoro-1-(5H-imidazo[4,5-c]pyridazin-3-yl)imidazolidin-2-one Chemical class FC1(N(C(N(C1)C1=NNC=2C(=C1)N=CN=2)=O)C1CCCCC1)F KGHLHKZDSODELI-UHFFFAOYSA-N 0.000 abstract 1
- 201000004681 Psoriasis Diseases 0.000 abstract 1
- 201000006417 multiple sclerosis Diseases 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 206010039073 rheumatoid arthritis Diseases 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 abstract 1
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
- A61K31/5025—Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Peptides Or Proteins (AREA)
Abstract
La invención proporciona ciertos compuestos de difluorociclohexil-imidazopiridazinil-imidazolidinona de Fórmula II como inhibidores de IL-17A, composiciones farmacéuticas de estos, y métodos para usar un compuesto de la Fórmula II para tratar ciertos síntomas de psoriasis, artritis reumatoide o esclerosis múltiple.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962789247P | 2019-01-07 | 2019-01-07 | |
| US201962842770P | 2019-05-03 | 2019-05-03 | |
| PCT/US2020/012115 WO2020146194A1 (en) | 2019-01-07 | 2020-01-03 | Imidazo[1,2-b]pyridazine il-17a inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CR20210357A true CR20210357A (es) | 2021-09-01 |
Family
ID=69423406
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CR20210357A CR20210357A (es) | 2019-01-07 | 2020-01-03 | Inhibidores de il-17a de imidazo[1,2-b]piridazina |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US12252491B2 (es) |
| EP (1) | EP3908585B1 (es) |
| JP (1) | JP7291226B2 (es) |
| KR (1) | KR102600451B1 (es) |
| CN (1) | CN113286795B (es) |
| AU (1) | AU2020207196B2 (es) |
| BR (1) | BR112021011095B1 (es) |
| CA (1) | CA3125788C (es) |
| CL (1) | CL2021001720A1 (es) |
| CO (1) | CO2021008776A2 (es) |
| CR (1) | CR20210357A (es) |
| DO (1) | DOP2021000132A (es) |
| EC (1) | ECSP21050201A (es) |
| ES (1) | ES2977743T3 (es) |
| IL (1) | IL284228B2 (es) |
| JO (1) | JOP20210179A1 (es) |
| MA (1) | MA54696A (es) |
| MX (1) | MX2021008176A (es) |
| NZ (1) | NZ777806A (es) |
| PE (1) | PE20212304A1 (es) |
| PH (1) | PH12021551632A1 (es) |
| SA (1) | SA521422452B1 (es) |
| SG (1) | SG11202105776WA (es) |
| TW (2) | TW202214648A (es) |
| WO (1) | WO2020146194A1 (es) |
Families Citing this family (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113164448A (zh) | 2018-12-19 | 2021-07-23 | 利奥制药有限公司 | 作为il-17的小分子调节剂的氨基酸苯胺类化合物 |
| GB201909190D0 (en) | 2019-06-26 | 2019-08-07 | Ucb Biopharma Sprl | Therapeutic agents |
| KR20230019507A (ko) | 2020-04-30 | 2023-02-08 | 얀센 파마슈티카 엔.브이. | Il-17의 조절제로서의 이미다조피리다진 |
| AU2021290172A1 (en) | 2020-06-12 | 2023-02-16 | Leo Pharma A/S | Small molecule modulators of IL-17 |
| WO2021255085A1 (en) | 2020-06-18 | 2021-12-23 | Leo Pharma A/S | Small molecule modulators of il-17 |
| US20230227435A1 (en) | 2020-06-18 | 2023-07-20 | Leo Pharma A/S | Small molecule modulators of il-17 |
| WO2021255086A1 (en) | 2020-06-18 | 2021-12-23 | Leo Pharma A/S | Small molecule modulators of il-17 |
| EP3943495A1 (en) | 2020-07-24 | 2022-01-26 | Leo Pharma A/S | Small molecule modulators of il-17 |
| CN113999234B (zh) * | 2020-07-28 | 2023-03-07 | 成都先导药物开发股份有限公司 | 一种免疫调节剂 |
| WO2022096411A1 (en) | 2020-11-09 | 2022-05-12 | UCB Biopharma SRL | Dicyclopropylmethyl derivatives as il-17 modulators |
| CN116406267A (zh) | 2020-11-09 | 2023-07-07 | Ucb生物制药有限责任公司 | 作为il-17调节剂的二环丙基甲基衍生物 |
| EP4259631A1 (en) | 2020-12-14 | 2023-10-18 | UCB Biopharma SRL | Imidazopyridazine derivatives as il-17 modulators |
| AR126255A1 (es) | 2021-07-01 | 2023-10-04 | UCB Biopharma SRL | Derivados de imidazotriazina como moduladores de il-17 |
| WO2023025783A1 (en) | 2021-08-23 | 2023-03-02 | Leo Pharma A/S | Small molecule modulators of il-17 |
| WO2023049887A1 (en) * | 2021-09-27 | 2023-03-30 | Janssen Pharmaceutica Nv | Imidazopyridazine il-17 inhibitor compounds |
| US12215111B2 (en) * | 2021-09-27 | 2025-02-04 | Janssen Pharmaceutica Nv | Imidazopyridazine IL-17 inhibitor compounds |
| CN118103372A (zh) * | 2021-11-04 | 2024-05-28 | 西藏海思科制药有限公司 | 一种可抑制il-17a的杂环化合物及其用途 |
| WO2023111181A1 (en) | 2021-12-16 | 2023-06-22 | Leo Pharma A/S | Small molecule modulators of il-17 |
| WO2023166172A1 (en) | 2022-03-04 | 2023-09-07 | Leo Pharma A/S | Small molecule modulators of il-17 |
| CN114736104B (zh) * | 2022-04-20 | 2024-04-19 | 上海恩氟佳科技有限公司 | 一种二氟乙醛缩半乙醇的合成方法 |
| CN119654325A (zh) * | 2022-05-19 | 2025-03-18 | 戴斯阿尔法公司 | 内酰胺取代的咪唑并哒嗪il-17a调节剂及其用途 |
| GB202210731D0 (en) | 2022-07-22 | 2022-09-07 | UCB Biopharma SRL | Therapeutic agents |
| WO2024115662A1 (en) | 2022-12-02 | 2024-06-06 | Leo Pharma A/S | Small molecule modulators of il-17 |
| WO2024138286A1 (en) * | 2022-12-26 | 2024-07-04 | Usynova Pharmaceuticals, Ltd. | Il-17a modulators |
| WO2024163365A1 (en) * | 2023-01-30 | 2024-08-08 | Dice Alpha, Inc. | Benzimidazole and aza-benzimidazole based il-17a modulators and uses thereof |
| IL322551A (en) * | 2023-02-13 | 2025-10-01 | Dice Alpha Inc | Imidazotriazine IL-17a modulators and their uses |
| CN121311483A (zh) * | 2023-03-28 | 2026-01-09 | 詹森药业有限公司 | 含内酰胺的咪唑并哒嗪il-17抑制剂化合物 |
| EP4695254A1 (en) * | 2023-04-11 | 2026-02-18 | Dice Alpha, Inc. | Substituted 6-imidazopyridazine il-17a modulators and uses thereof |
| WO2025133234A1 (en) | 2023-12-22 | 2025-06-26 | Draupnir Bio Aps | Sortilin binders and bifunctional compounds thereof |
| WO2025175249A1 (en) | 2024-02-14 | 2025-08-21 | Olema Pharmaceuticals, Inc. | Estrogen receptor modulators and uses thereof |
| WO2025247285A1 (zh) * | 2024-05-28 | 2025-12-04 | 西藏海思科制药有限公司 | 一种可抑制il-17a的杂环化合物制备及其用途 |
| WO2026039168A1 (en) | 2024-08-12 | 2026-02-19 | Dice Alpha, Inc. | Il-17a inhibitors |
| WO2026039172A1 (en) | 2024-08-12 | 2026-02-19 | Dice Alpha, Inc. | Il-17a inhibitors |
| WO2026039167A1 (en) | 2024-08-12 | 2026-02-19 | Dice Alpha, Inc. | Il-17a inhibitors |
| WO2026039171A1 (en) | 2024-08-12 | 2026-02-19 | Dice Alpha, Inc. | Il-17a inhibitors |
| WO2026039170A1 (en) | 2024-08-12 | 2026-02-19 | Dice Alpha, Inc. | Il-17a inhibitors |
| WO2026073936A1 (en) * | 2024-10-02 | 2026-04-09 | UCB Biopharma SRL | Imidazotriazine derivatives as il-17 modulators |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9702213D0 (en) * | 1996-02-24 | 1997-03-26 | Zeneca Ltd | Chemical compounds |
| JP2009502734A (ja) | 2005-07-29 | 2009-01-29 | アステラス製薬株式会社 | Ｌｃｋ阻害剤としての縮合複素環 |
| WO2007104696A1 (en) * | 2006-03-15 | 2007-09-20 | Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. | Antimalarial agents having polyaromatic structure |
| JP5313909B2 (ja) * | 2006-11-13 | 2013-10-09 | アイコス コーポレイション | 炎症性疾患および癌の処置のためのチエノピリミジノン |
| WO2013116682A1 (en) | 2012-02-02 | 2013-08-08 | Ensemble Therapeutics Corporation | Macrocyclic compounds for modulating il-17 |
| ES2666353T3 (es) * | 2012-09-06 | 2018-05-04 | Bristol-Myers Squibb Company | Inhibidores de JAK3 de imidazopiridazina y su uso para el tratamiento de enfermedades inflamatorias y autoinmunitarias |
| WO2014066726A2 (en) | 2012-10-26 | 2014-05-01 | Ensemble Therapeutics Corporation | Compounds for modulating il-17 |
| UA112028C2 (uk) * | 2012-12-14 | 2016-07-11 | Пфайзер Лімітед | Похідні імідазопіридазину як модулятори гамка-рецептора |
| JP2016509036A (ja) | 2013-02-20 | 2016-03-24 | バイエル・ファルマ・アクティエンゲゼルシャフト | Ｍｋｎｋ１阻害剤としての置換イミダゾ［１，２−ｂ］ピリダジン |
| EP3080131B1 (en) * | 2013-12-10 | 2018-10-10 | Bristol-Myers Squibb Company | Imidazopyridazine compounds useful as modulators of il-12, il-23 and/or ifn alpha responses |
| US10385034B2 (en) | 2014-09-05 | 2019-08-20 | The Cleveland Clinic Foundation | Flavonoid IL-17A inhibitors |
| EA201890767A1 (ru) | 2015-09-23 | 2019-09-30 | Рита Фармасьютикалз, Инк. | C4-модифицированные производные олеаноловой кислоты для ингибирования il-17 и других применений |
| KR102782807B1 (ko) * | 2015-11-18 | 2025-03-14 | 브리스톨-마이어스 스큅 컴퍼니 | Il-12, il-23 및/또는 ifn 알파 반응의 조정제로서 유용한 이미다조피리다진 화합물 |
| GB201709456D0 (en) | 2017-06-14 | 2017-07-26 | Ucb Biopharma Sprl | Therapeutic agents |
| EP3740478B1 (en) | 2018-01-15 | 2023-11-01 | UCB Biopharma SRL | Fused imidazole derivatives as il-17 modulators |
| WO2019223718A1 (zh) | 2018-05-22 | 2019-11-28 | 成都先导药物开发股份有限公司 | 一种免疫调节剂 |
| CN113164448A (zh) | 2018-12-19 | 2021-07-23 | 利奥制药有限公司 | 作为il-17的小分子调节剂的氨基酸苯胺类化合物 |
| TWI839461B (zh) | 2019-02-06 | 2024-04-21 | 美商戴斯阿爾法股份有限公司 | Il-17a調節物及其用途 |
-
2020
- 2020-01-02 TW TW111100669A patent/TW202214648A/zh unknown
- 2020-01-02 TW TW109100073A patent/TWI752400B/zh not_active IP Right Cessation
- 2020-01-03 AU AU2020207196A patent/AU2020207196B2/en active Active
- 2020-01-03 PE PE2021001117A patent/PE20212304A1/es unknown
- 2020-01-03 MX MX2021008176A patent/MX2021008176A/es unknown
- 2020-01-03 CA CA3125788A patent/CA3125788C/en active Active
- 2020-01-03 US US17/419,997 patent/US12252491B2/en active Active
- 2020-01-03 WO PCT/US2020/012115 patent/WO2020146194A1/en not_active Ceased
- 2020-01-03 PH PH1/2021/551632A patent/PH12021551632A1/en unknown
- 2020-01-03 SG SG11202105776WA patent/SG11202105776WA/en unknown
- 2020-01-03 CN CN202080008309.9A patent/CN113286795B/zh active Active
- 2020-01-03 ES ES20703322T patent/ES2977743T3/es active Active
- 2020-01-03 BR BR112021011095-0A patent/BR112021011095B1/pt active IP Right Grant
- 2020-01-03 MA MA054696A patent/MA54696A/fr unknown
- 2020-01-03 JP JP2021539549A patent/JP7291226B2/ja active Active
- 2020-01-03 NZ NZ777806A patent/NZ777806A/en unknown
- 2020-01-03 CR CR20210357A patent/CR20210357A/es unknown
- 2020-01-03 KR KR1020217020765A patent/KR102600451B1/ko active Active
- 2020-01-03 EP EP20703322.6A patent/EP3908585B1/en active Active
- 2020-01-03 IL IL284228A patent/IL284228B2/en unknown
-
2021
- 2021-06-22 DO DO2021000132A patent/DOP2021000132A/es unknown
- 2021-06-25 CL CL2021001720A patent/CL2021001720A1/es unknown
- 2021-07-01 CO CONC2021/0008776A patent/CO2021008776A2/es unknown
- 2021-07-01 SA SA521422452A patent/SA521422452B1/ar unknown
- 2021-07-07 EC ECSENADI202150201A patent/ECSP21050201A/es unknown
- 2021-07-07 JO JOP/2021/0179A patent/JOP20210179A1/ar unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ECSP21050201A (es) | Inhibidores de imidazo[1,2-b]piridazina il-17a | |
| ECSP22087539A (es) | Inhibidores de kras tricíclicos fusionados | |
| ECSP22029777A (es) | Heterociclos bic?clicos como inhibidores de fgfr | |
| CL2021002882A1 (es) | Inhibidores de fgfr y métodos de uso de los mismos | |
| EA201992584A1 (ru) | Новые ингибиторы map4k1 | |
| MX2022007171A (es) | Compuestos cíclicos y métodos de uso de estos. | |
| CL2020002275A1 (es) | Compuestos diólicos de aminopirazina como inhibidores de pi3k-y. | |
| UA113156C2 (xx) | Циклобутилзаміщені похідні піролопіридину й піролопіримідину як інгібітори jak | |
| CL2010001641A1 (es) | Compuestos derivados de heterociclos biciclicos sustituidos; composicion farmaceutica; y su uso como inhibidores de la quinasa mek para tratar enfermedades hiperproliferativas e inflamatorias tales como cancer y artritis reumatoide entre otras. | |
| ES2192192T3 (es) | Dieteres de catecol como inhibidores selectivos de pde iv. | |
| MX2022002711A (es) | Nuevos inhibidores heterociclicos de monoacilglicerol lipasa (magl). | |
| EA201390015A1 (ru) | Композиции и способы ингибирования пути jak | |
| BR112022005627A2 (pt) | Composto de fórmula estrutural i ou um sal do mesmo, composição farmacêutica e uso de um composto | |
| PA8601001A1 (es) | Fenacilo 2-hidroxi-3-diaminoalcanos | |
| CL2021000843A1 (es) | Inhibidores de pde4 que contienen boro | |
| BR112022013488A2 (pt) | Pirazolo-pirimidinas substituídas e seu uso | |
| MX383520B (es) | Nuevos compuestos de tipo tetrahidropirimidodiazepina y dihidropiridodiazepina para tratar el dolor y afecciones relacionadas con el dolor | |
| MX2022004565A (es) | Tienopirimidonas como inhibidores de trpa1. | |
| CL2024002824A1 (es) | Inhibidores de tyk2 y usos de los mismos | |
| BR112016023299A8 (pt) | composto tricíclico e inibidor de jak, agente preventivo, terapêutico ou de melhoria para doenças contra as quais inibição de jak é eficaz e para artrite reumatoide, medicamento e utilização desses compostos | |
| JOP20240266A1 (ar) | مركبات تريازولو ثلاثية الحلقة كمثبطات dgk | |
| EP4706394A3 (en) | Use of alkoxypyrazoles as nitrification inhibitors | |
| MX2022004564A (es) | Tienopirimidonas como inhibidores de trpa1. | |
| MX2023009059A (es) | Antagonistas de gpr84 y usos de estos. | |
| EA202191464A1 (ru) | ИМИДАЗО[1,2-b]ПИРИДАЗИНОВЫЕ ИНГИБИТОРЫ IL-17A |